The incidence and predictors of HCC in REVEAL chronic hepatitis B patients with incident spontaneous HBsAg loss

被引:0
|
作者
Jeng, Rachel Wen-Juei [1 ,2 ]
Pan, Mei-Hung [3 ]
Liu, Jessica [3 ]
Lee, Mei-Hsuan [4 ]
Batrla-Utermann, Richard [5 ]
Lu, Sheng-Nan [6 ]
Wang, Li-Yu [7 ]
Chen, Chien-Jen [3 ]
Yang, Hwai-I [3 ]
机构
[1] Linkou Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Acad Sinica, Genom Res Ctr, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[5] Roche Diagnost, Basel, Switzerland
[6] Kaohsiung Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Kaohsiung, Taiwan
[7] Mackay Med Coll, New Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PO-1788
引用
收藏
页码:S725 / S725
页数:1
相关论文
共 50 条
  • [41] HBsAg Kinetics Prior to HBsAg Loss after Cessation of Entecavir Therapy in Hbeag-Negative Chronic Hepatitis B Patients
    Jeng, Wen-Juei
    Chang, Ming-Ling
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 : 272A - 272A
  • [42] Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir
    Takkenberg, R. Bart
    Jansen, Louis
    de Niet, Annikki
    Zaaijer, Hans L.
    Weegink, Christine J.
    Terpstra, Valeska
    Dijkgraaf, Marcel G. W.
    Molenkamp, Richard
    Jansen, Peter L. M.
    Koot, Maarten
    Rijckborst, Vincent
    Janssen, Harry L. A.
    Beld, Marcel G. H. M.
    Reesink, Hendrik W.
    ANTIVIRAL THERAPY, 2013, 18 (07) : 895 - 904
  • [43] Evaluation of Chronic Hepatitis B Infection in Patients with Seronegative HbsAg
    Parizad, E. Gholami
    Khosravi, A.
    Parizad, E. Gholami
    Sadeghifard, N.
    Ghafourian, S.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2012, 41 (02) : 100 - 104
  • [44] HBsAg Screening in the Family Members of the Patients with Chronic Hepatitis B
    Kayabas, Uner
    Bayindir, Yasar
    Yologlu, Salim
    Akdogan, Dogan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2007, 12 (03): : 128 - 132
  • [45] Clinical Implications of HBsAg Quantification in Patients with Chronic Hepatitis B
    Vigano, Mauro
    Lampertico, Pietro
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2012, 18 (02): : 81 - 86
  • [46] CLEARANCE OF HBSAG IN 7 PATIENTS WITH CHRONIC HEPATITIS-B
    ADACHI, H
    KANEKO, S
    MATSUSHITA, E
    INAGAKI, Y
    UNOURA, M
    KOBAYASHI, K
    HEPATOLOGY, 1992, 16 (06) : 1334 - 1337
  • [47] Peripheral soluble protein, transcriptomic, and methylation biomarkers associated with HBsAg loss in patients with chronic hepatitis B
    Wallin, Jeffrey
    Chen, Diana
    Li, Ruidong
    Kim, Sam
    Gindin, Yevgeniy
    Suri, Vithika
    Podlaha, Ondrej
    Li, Li
    Gaggar, Anuj
    JOURNAL OF HEPATOLOGY, 2020, 73 : S576 - S576
  • [48] Improvement of HBsAg Loss by additional PEG IFN in Nucleosides Analogs treated Chronic Hepatitis B Patients
    Wu, Zhongwen
    Sheng, Jifang
    Li, Lanjuan
    HEPATOLOGY, 2012, 56 : 404A - 404A
  • [49] Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B
    Chen, Chien-Hung
    Peng, Cheng-Yuan
    Hu, Tsung-Hui
    Wang, Jing-Houng
    Hung, Chao-Hung
    Lu, Sheng-Nan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (03) : 334 - 345
  • [50] HIGHLY SENSITIVE HEPATITIS B CORE-RELATED ANTIGEN (HBCRAG) MEASUREMENTS CAN PREDICT HEPATOCELLULAR CARCINOMA (HCC) RISK AND HEPATITIS B SURFACE ANTIGEN (HBSAG) LOSS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Mariko
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Kumada, Hiromitsu
    HEPATOLOGY, 2024, 80 : S2002 - S2003